Wulff AB et al. found RC mediated 37% of the observed 41% lower risk of ischemic vascular disease and 54% of the observed 36% lower risk of ischemic heart disease in APOC3 loss-of-function heterozygotes versus noncarriers [53]. Here, APOC3 is linked to coronary artery disorder.